LAZCLUZE Trademark

Trademark Overview

On Tuesday, March 30, 2021, a trademark application was filed for LAZCLUZE with the United States Patent and Trademark Office. The USPTO has given the LAZCLUZE trademark a serial number of 90611510. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, August 6, 2024. This trademark is owned by JOHNSON & JOHNSON. The LAZCLUZE trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
lazcluze

General Information

Serial Number90611510
Word MarkLAZCLUZE
Filing DateTuesday, March 30, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Friday, April 2, 2021NEW APPLICATION ENTERED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Tuesday, July 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 8, 2022SOU EXTENSION 1 FILED
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 8, 2022SOU EXTENSION 1 GRANTED
Monday, January 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 26, 2023SOU EXTENSION 2 FILED
Thursday, January 26, 2023SOU EXTENSION 2 GRANTED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 27, 2023SOU EXTENSION 3 FILED
Thursday, July 27, 2023SOU EXTENSION 3 GRANTED
Saturday, July 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 22, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024SOU EXTENSION 5 FILED
Monday, February 3, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, August 6, 2024SOU EXTENSION 5 GRANTED
Monday, January 22, 2024SOU EXTENSION 4 FILED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

lazcluze diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory